BNT162b2 Vaccination efficacy is marginally affected by the SARS-CoV-2 B.1.351 variant in fully vaccinated individuals

Orna Mor, Neta S. Zuckerman, Itay Hazan, Ronen Fluss, Nachman Ash, Netanel Ginish, Ella Mendelson, Sharon Alroy-Preis, Laurence Freedman, Amit Huppert
doi: https://doi.org/10.1101/2021.07.20.21260833

Article usage

Article usage: July 2021 to January 2025

AbstractFullPdf
Jul 2021107523261
Aug 202140326192
Sep 20212891892
Oct 2021138854
Nov 2021133736
Dec 2021105028
Jan 202251510
Feb 202243210
Mar 20223414
Apr 20222405
May 202236410
Jun 202226010
Jul 20222101
Aug 20222538
Sep 20223328
Oct 20223114
Nov 20222826
Dec 20222519
Jan 20232628
Feb 20232869
Mar 20231843
Apr 202332616
May 202315111
Jun 20231443
Jul 202316110
Aug 202320119
Sep 20236942
Oct 20232414
Nov 202320719
Dec 20231506
Jan 2024813
Feb 20242076
Mar 202410212
Apr 20241946
May 2024954
Jun 20242034
Jul 20241427
Aug 202422413
Sep 202424410
Oct 20241546
Nov 20241127
Dec 20241128
Jan 2025112
Back to top
Posted July 23, 2021.
Download PDF
Data/Code
Email
BNT162b2 Vaccination efficacy is marginally affected by the SARS-CoV-2 B.1.351 variant in fully vaccinated individuals
Orna Mor, Neta S. Zuckerman, Itay Hazan, Ronen Fluss, Nachman Ash, Netanel Ginish, Ella Mendelson, Sharon Alroy-Preis, Laurence Freedman, Amit Huppert
medRxiv 2021.07.20.21260833; doi: https://doi.org/10.1101/2021.07.20.21260833
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area